Camilla Bernt Wulff

Camilla Bernt Wulff

Auto-generated profile, based on publicly available information

Camilla Bernt Wulff

Center of Fetal Medicine, Department of Obstetrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2019 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
LSL. J. Salomon
L. J. Salomon
ASAlexandros Sotiriadis
Alexandros Sotiriadis
CWC. B. Wulff
C. B. Wulff
AOA. Odibo
A. Odibo
RARanjit Akolekar
Ranjit Akolekar
Objective: To estimate the procedure‐related risk of miscarriage after amniocentesis and chorionic villus sampling (CVS) based on a systematic review of the literature and an updated meta‐analysis.Methods: A search of MEDLINE, EMBASE and The Cochrane Library was carried out to identify studies reporting complications following CVS or amniocentesis. Eligible for inclusion were large controlled studies reporting data for pregnancy loss prior to 24 weeks' gestation. Study authors were contacted when required to identify additional necessary data. Data for cases that had an invasive procedure and controls were inputted into contingency tables and the risk of miscarriage was estimated for each study. Summary statistics based on a random‐effects model were calculated after taking into account the weighting for each study included in the systematic review. Procedure‐related risk of miscarriage was estimated as a weighted risk difference from the summary statistics for cases and controls. Subgroup analyses were performed according to the similarity in risk levels for chromosomal abnormality between the invasive‐testing and control groups. Heterogeneity was assessed using the I2 statistic. Egger's bias was estimated to assess reporting bias in published studies.Results: The electronic search yielded 2943 potential citations, from which 12 controlled studies for amniocentesis and seven for CVS were selected for inclusion in the systematic review. A total of 580 miscarriages occurred following 63 723 amniocentesis procedures, resulting in a weighted risk of pregnancy loss of 0.91% (95% CI, 0.73–1.09%). In the control group, there were 1726 miscarriages in 330 469 pregnancies with a loss rate of 0.58% (95% CI, 0.47–0.70%). The weighted procedure‐related risk of miscarriage following amniocentesis was 0.30% (95% CI, 0.11–0.49%; I2 = 70.1%). A total of 163 miscarriages occurred following 13 011 CVS procedures, resulting in a risk of pregnancy loss of 1.39% (95% CI, 0.76–2.02%). In the control group, there were 1946 miscarriages in 232 680 pregnancies with a loss rate of 1.23% (95% CI, 0.86–1.59%). The weighted procedure‐related risk of miscarriage following CVS was 0.20% (95% CI, −0.13 to 0.52%; I2 = 52.7%). However, when studies including only women with similar risk profiles for chromosomal abnormality in the intervention and control groups were considered, the procedure‐related risk for amniocentesis was 0.12% (95% CI, −0.05 to 0.30%; I2 = 44.1%) and for CVS it was −0.11% (95% CI, −0.29 to 0.08%; I2 = 0%).Conclusions: The procedure‐related risks of miscarriage following amniocentesis and CVS are lower than currently quoted to women. The risk appears to be negligible when these interventions were compared to control groups of the same risk profile. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

19 November 2015 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
CWC. B. Wulff
C. B. Wulff
TGT. A. Gerds
T. A. Gerds
LRLine Rode
Line Rode
CEC. K. Ekelund
C. K. Ekelund
OPO. B. Petersen
O. B. Petersen
TGthe Danish Fetal Medicine Study Group
the Danish Fetal Medicine Study Group
Objective: To assess prospectively the risk of fetal loss associated with chorionic villus sampling (CVS) and amniocentesis (AC) following combined first‐trimester screening (cFTS) for Down syndrome.Methods: This was a nationwide population‐based study (Danish Fetal Medicine Database, 2008–2010) including 147 987 women with singleton pregnancy who underwent cFTS. Propensity score stratification was used to assess the risk of fetal loss with and without invasive testing. Analyses were performed between 3 and 21 days after cFTS for CVS and between 28 and 42 days after cFTS for AC. Results are reported as average risk differences with 95% CIs.Results: The risks of miscarriage and stillbirth were not higher in women exposed to CVS or AC compared with unexposed women, independent of the analysis time‐point. The average effect of CVS on risk of miscarriage was –0.08% (95% CI, −0.64; 0.47) at 3 days and –0.21% (95% CI, –0.58; 0.15) at 21 days after cFTS, while the effect on risk of stillbirth was –0.18% (95% CI, –0.50; 0.13) at 3 days and –0.27% (95% CI, –0.58; 0.04) at 21 days after cFTS. Regarding the effect of AC on risk of miscarriage, the analysis at 28 days after cFTS showed an average effect of 0.56% (95% CI, –0.21; 1.33), while the effect on risk of stillbirth was 0.09% (95% CI, –0.39; 0.58) at 42 days after cFTS.Conclusion: Neither CVS nor AC was associated with increased risk of miscarriage or stillbirth. These findings indicate that the procedure‐related risk of CVS and AC is very low. Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.

2 April 2018 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
CWC. B. Wulff
C. B. Wulff
LRLine Rode
Line Rode
SRS. Rosthøj
S. Rosthøj
EHE. Hoseth
E. Hoseth
OPO. B. Petersen
O. B. Petersen
ATA. Tabor
A. Tabor

1 February 2018 in BioMed Research International
Verified
Journal Article
Open access
PDF file
CBCharlotte Rosenkrantz Bodin
Charlotte Rosenkrantz Bodin
MRMikkel Mylius Rasmussen
Mikkel Mylius Rasmussen
ATAnn Tabor
Ann Tabor
LWLena Westbom
Lena Westbom
ETEleonor Tiblad
Eleonor Tiblad
OPOlav Bjørn Petersen
Olav Bjørn Petersen
Objectives. The aim of this study was to assess the incidence, the prenatal detection rate by ultrasound, and the pregnancy outcome of spina bifida (SB) in Denmark (DK) in 2008–2015 and to compare results to national data from Sweden. Methods. Data were retrieved from the Danish Fetal Medicine Database, which includes International Classification of Diseases- (ICD-) 10 codes for pre- or postnatally diagnoses and pregnancy outcome. Missing data were obtained from the National Patient Register. Livebirth data with myelomeningocele (MMC) in Sweden were obtained from different databases. Results. There were 234 cases with SB in DK in 2008–2015. The incidence of SB was 4.9 : 10,000; 89% were detected with ultrasound prior to week 22; 90% of these pregnancies were terminated (ToP); 91% were isolated malformations of which 11% showed abnormal karyotype. The incidence of newborns with MMC was 1.3 : 10,000 in Sweden. Conclusions. Ultrasound screening has a major impact on the epidemiology of SB. The prenatal detection rate of SB was high, and most SB cases were isolated and had a normal karyotype. Among women with a prenatal fetal diagnosis of SB, 90% chose to have ToP. The incidence of newborns with SB was higher in Sweden than in DK.

1 May 2016 in Obstetrical & Gynecological Survey
Verified
Journal Article
Closed access
CWC. B. Wulff
C. B. Wulff
TGT. A. Gerds
T. A. Gerds
LRL. Rode
L. Rode
CEC. K. Ekelund
C. K. Ekelund
OPO. B. Petersen
O. B. Petersen
ATA. Tabor
A. Tabor
Ed from Ultrasound Obstet Gynecol 2016;47:38–44 The risk of miscarriage after chorionic villus sampling (CVS) and amniocentesis (AC) was investigated in randomized clinical trials in the 1980s and 1990s. Studies have compared CVS with AC and found comparable risk of miscarriage after the 2 procedures.

1 October 2013 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
CWC. B. Wulff
C. B. Wulff
SBS. Ball
S. Ball
LRL. Rode
L. Rode
APA. Pinborg
A. Pinborg
ALA. Loft
A. Loft
ATA. Tabor
A. Tabor
Click on the article title to read more.